Virtus ETF Advisers’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-125,062
Closed -$111K 506
2022
Q4
$111K Buy
125,062
+50,975
+69% +$67.6K 0.06% 435
2022
Q3
$116K Buy
74,087
+540
+0.7% +$1.23K 0.05% 405
2022
Q2
$148K Buy
73,547
+48,120
+189% +$83.2K 0.05% 321
2022
Q1
$59K Sell
25,427
-1,501
-6% -$4.68K 0.03% 360
2021
Q4
$125K Buy
26,928
+4,463
+20% +$27.7K 0.05% 368
2021
Q3
$171K Sell
22,465
-1,181
-5% -$10K 0.08% 308
2021
Q2
$229K Sell
23,646
-16,454
-41% -$131K 0.09% 246
2021
Q1
$332K Buy
40,100
+713
+2% +$7.53K 0.14% 220
2020
Q4
$269K Sell
39,387
-27,464
-41% -$221K 0.11% 283
2020
Q3
$745K Sell
66,851
-9,133
-12% -$83.6K 0.39% 99
2020
Q2
$477K Sell
75,984
-12,358
-14% -$47.3K 0.23% 155
2020
Q1
$163K Sell
88,342
-12,874
-13% -$37.1K 0.07% 284
2019
Q4
$342K Buy
101,216
+21,002
+26% +$50.1K 0.06% 285
2019
Q3
$172K Sell
80,214
-4,468
-5% -$10.4K 0.03% 270
2019
Q2
$226K Sell
84,682
-23,079
-21% -$83.1K 0.05% 281
2019
Q1
$512K Sell
107,761
-16,062
-13% -$42.1K 1.09% 28
2018
Q4
$297K Buy
123,823
+61,132
+98% +$200K 0.05% 114
2018
Q3
$276K Sell
62,691
-46,025
-42% -$255K 0.03% 190
2018
Q2
$783K Buy
+108,716
New +$740K 0.69% 42
2016
Q4
Sell
-40,438
Closed -$313K 197
2016
Q3
$313K Hold
40,438
0.15% 96
2016
Q2
$226K Buy
40,438
+4,308
+12% +$27.5K 0.17% 119
2016
Q1
$194K Buy
+36,130
New +$210K 0.27% 90

Other funds holding SRNE